Skip to content
OpenCapital
Get started

Calidi Biotherapeutics CLDI Q1 2026 earnings

Reported May 14, 2026 · Before market open

EPS-$0.43

Next report

Aug 18, 2026 (In 2 weeks)

Versus estimates

Revenue

Q4 2024$1.5M

Diluted EPS

Q1 2026-$0.43
Q4 2025-$0.57Beat by $0.99Q3 2025-$2.21Miss by $0.53Q2 2025-$1.99Miss by $0.07Q1 2025-$2.16Miss by $2.01Q4 2024-$0.51Miss by $0.14

Ask the moment Calidi Biotherapeutics reports.

Connect your AI and ask the moment the filing drops. It reads the release, surfaces what management said, and gives you its own read.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

When did Calidi Biotherapeutics report Q1 2026 earnings?
Calidi Biotherapeutics (CLDI) reported Q1 2026 earnings on May 14, 2026 before market open.
What were Calidi Biotherapeutics's Q1 2026 revenue and EPS?
Calidi Biotherapeutics reported eps of $-0.43 for Q1 2026.
How did Calidi Biotherapeutics's Q1 2026 results compare year-over-year?
Compared to the same quarter a year prior, eps grew 80.1% from $-2.16.
Where can I find Calidi Biotherapeutics's Q1 2026 SEC filings?
You can read the 8-K earnings release (0001493152-26-023094) and the 10-Q periodic report (0001493152-26-023140) directly on SEC EDGAR. The filing index links above go to sec.gov.